S4, F and G) breast cancer cells, which also express IGF-II, to the Matrigel invasion chambers (31), we again saw a significant reduction in invasion after IGFBP2 or anti–IGF-II treatments (fig. This evidence concerns the gene IGFBP2 and breast carcinoma.